PQ 277
277. Deputy Michael Harty asked the Minister for Health if he will direct the HSE to review its decision and the processes used in arriving at the decision not to approve for reimbursement of the drug Translarna for treatment of Duchenne muscular dystrophy in view of the fact that many other countries have given such approval; and if he will make a statement on the matter. [43401/17]
Introduced
17 October 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
17 October 2017
Summary
277. Deputy Michael Harty asked the Minister for Health if he will direct the HSE to review its decision and the processes used in arriving at the decision not to approve for reimbursement of the drug Translarna for treatment of Duchenne muscular dystrophy in view of the fact that many other countries have given such approval; and if he will make a statement on the matter. [43401/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 17 October 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-10-17/277/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-10-17/pq_277